ARCHIVES

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

This article is from The Cancer Letter archive.

Vol. 31 No. 39 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: The Walue of Quality of Life Data In Judging Patient Benefit: experts Respond To ODAC

September 3, 1999

FDA Begins To Examine Its Role In Allowing Misleading Consumer Advertising.

May 18, 2007

DCBD To Fund Diagnostic Clinical Trials By CCOPs, Cooperative Groups

June 30, 1989

ASCO Annual Meeting: NCI goals: Expand Clinical Trials, Build Informatics Network

May 30, 1997

Race, Age Play Role In Delay Of Surgery For Breast Cancer

December 28, 2007

Kennedy Bills Would Authorize Senior Scientist Service, New Foundation, Construction Grants

July 28, 1989